1. Home
  2. AIV vs ADPT Comparison

AIV vs ADPT Comparison

Compare AIV & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIV
  • ADPT
  • Stock Information
  • Founded
  • AIV 1975
  • ADPT 2009
  • Country
  • AIV United States
  • ADPT United States
  • Employees
  • AIV N/A
  • ADPT N/A
  • Industry
  • AIV Real Estate Investment Trusts
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIV Real Estate
  • ADPT Health Care
  • Exchange
  • AIV Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • AIV 1.2B
  • ADPT 1.1B
  • IPO Year
  • AIV 1994
  • ADPT 2019
  • Fundamental
  • Price
  • AIV $8.75
  • ADPT $7.67
  • Analyst Decision
  • AIV
  • ADPT Strong Buy
  • Analyst Count
  • AIV 0
  • ADPT 5
  • Target Price
  • AIV N/A
  • ADPT $9.40
  • AVG Volume (30 Days)
  • AIV 995.6K
  • ADPT 2.2M
  • Earning Date
  • AIV 05-07-2025
  • ADPT 05-06-2025
  • Dividend Yield
  • AIV 6.94%
  • ADPT N/A
  • EPS Growth
  • AIV N/A
  • ADPT N/A
  • EPS
  • AIV N/A
  • ADPT N/A
  • Revenue
  • AIV $208,679,000.00
  • ADPT $178,957,000.00
  • Revenue This Year
  • AIV $6.96
  • ADPT $21.21
  • Revenue Next Year
  • AIV N/A
  • ADPT $21.98
  • P/E Ratio
  • AIV N/A
  • ADPT N/A
  • Revenue Growth
  • AIV 11.60
  • ADPT 5.10
  • 52 Week Low
  • AIV $7.68
  • ADPT $2.28
  • 52 Week High
  • AIV $9.49
  • ADPT $9.01
  • Technical
  • Relative Strength Index (RSI)
  • AIV 48.85
  • ADPT 47.20
  • Support Level
  • AIV $8.47
  • ADPT $6.92
  • Resistance Level
  • AIV $8.78
  • ADPT $9.01
  • Average True Range (ATR)
  • AIV 0.17
  • ADPT 0.62
  • MACD
  • AIV -0.01
  • ADPT 0.04
  • Stochastic Oscillator
  • AIV 53.85
  • ADPT 51.36

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: